Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

A new mouse model helps understand and find treatments for alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Upadacitinib effectively treated severe hair loss in a child.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

The KEBOT system is a highly accurate AI tool for analyzing hair transplants.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

Blocking mTORC1 reduces skin tumor growth in mice.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The treatment showed promising results in improving advanced-stage hair loss.

Gunja has potential for hair growth, fertility control, immune support, and more, but needs careful handling due to toxicity.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

ICP5249 helps hair grow by activating a specific cell pathway.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A patient with complete hair loss regrew all her hair using tofacitinib.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

A specific RNA can help hair growth in baldness by boosting stem cell activity.

MPA increases cancer spread by boosting Eph A2 activity.